Study to examine the association between fasting glucose and mortality by age in patients with diabetes.
Read More »Adverse Effects of Short-Term Corticosteroid Use in Diabetes Mellitus
Is preventive medication the key to reducing risk of fractures, VTEs, and sepsis?
Read More »Study Shows Advantage of SGLT2’s Over DPP-4’s
Systematic review and meta-analysis show lead in HbA1c reduction, weight loss, and favorable fasting blood glucose levels.
Read More »Correlation of Depression and Severe Dysglycemia in T1DM
Patients with type 1 diagnosed with depression said to be in danger of experiencing more severe episodes of hypoglycemia and hyperglycemia.
Read More »How To Overcome The Complexities of Treatment Decisions For Patients With Type 2 Diabetes, Part 2
Costs vs. Outcomes for Patients With Type 2 Diabetes: The issue of cost in healthcare is a central point in the discussion of the future of medicine. While much is made of the cost of end-of-life care, many of the dollars spent yearly are focused on the treatment of chronic diseases like diabetes. The estimated yearly cost of diabetes care was $245 billion in the U.S. in 2012, the last year for which numbers have been reported. $50 billion of that was related to prescription drug purchases.
Read More »Semaglutide Shows Superiority Over Exenatide ER in Head-to-Head Trial
Battle between two GLP-1 receptor agonists proves semaglutide achieves favorable HbA1c levels, decreased mean body weight.
Read More »Non-adherence to Metformin Versus Therapeutic Failure: When is it Appropriate to Switch to Second-Line Therapies?
Patients who skipped initial treatment with metformin and were instead started on second-line antihyperglycemic medication more likely to need dual therapy or insulin to control T2.
Read More »Controversy Between SGLT-2 Inhibitors and GLP-1 Agonists as Preferred Second-Line Therapy
Patient specific considerations have to be taken into account prior to choosing GLP-1 agonist or SGLT2 inhibitor as second-line anti-hyperglycemic agent.
Read More »Is Insulin Secretion and Sensitivity Contingent upon BMI Fluctuations?
Patients projected to have increase in body mass index also likely to develop increased plasma glucose levels and have diminished insulin response.
Read More »Stroke and Dementia Risks With Sugars and Artificial Sweeteners: Fact or Fiction?
Researchers use data from large ongoing cohort study to look for connection. In a recent study, researchers concluded that sugar and artificially sweetened beverage intake have been linked to cardiometabolic risk factors, which increase the risk of cerebrovascular disease and dementia. The study examined whether sugar or artificially sweetened beverage …
Read More »